Back to Search
TIFFANY OLIPHANT, PHARM.D
PHARM.D
Pharmacist
NPI: 1871836981Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
PS49042(FL)
Research & Publications (20)
Fusion loop peptide of the West Nile virus envelope protein is essential for pathogenesis and is recognized by a therapeutic cross-reactive human monoclonal antibody.
PMID 19535627·J Immunol·2009
7-preclinical
Development of resistance to passive therapy with a potently neutralizing humanized monoclonal antibody against West Nile virus.
PMID 19527169·J Infect Dis·2009
7-preclinical
Human monoclonal antibodies against West Nile virus induced by natural infection neutralize at a postattachment step.
PMID 19386704·J Virol·2009
7-preclinical
The host immunologic response to West Nile encephalitis virus.
PMID 19273254·Front Biosci (Landmark Ed)·2009
6-review
Maturation of West Nile virus modulates sensitivity to antibody-mediated neutralization.
PMID 18464894·PLoS Pathog·2008
7-preclinical
Fast nonlinear image reconstruction for scanning impedance imaging.
PMID 18334388·IEEE Trans Biomed Eng·2008
8-other
The stoichiometry of antibody-mediated neutralization and enhancement of West Nile virus infection.
PMID 18005691·Cell Host Microbe·2007
8-other
Type- and subcomplex-specific neutralizing antibodies against domain III of dengue virus type 2 envelope protein recognize adjacent epitopes.
PMID 17881453·J Virol·2007
7-preclinical
Induction of epitope-specific neutralizing antibodies against West Nile virus.
PMID 17715236·J Virol·2007
7-preclinical
The molecular basis of antibody-mediated neutralization of West Nile virus.
PMID 17555373·Expert Opin Biol Ther·2007
6-review
Simple linear models of scanning impedance imaging for fast reconstruction of relative conductivity of biological samples.
PMID 17073338·IEEE Trans Biomed Eng·2006
8-other
Longitudinal population analysis of dual infection with recombination in two strains of HIV type 1 subtype B in an individual from a Phase 3 HIV vaccine efficacy trial.
PMID 17067266·AIDS Res Hum Retroviruses·2006
3-trial
Antibody recognition and neutralization determinants on domains I and II of West Nile Virus envelope protein.
PMID 17035317·J Virol·2006
4-observational
Protective and therapeutic capacity of human single-chain Fv-Fc fusion proteins against West Nile virus.
PMID 16282460·J Virol·2005
7-preclinical
Structural basis of West Nile virus neutralization by a therapeutic antibody.
PMID 16193056·Nature·2005
7-preclinical
Complement activation is required for induction of a protective antibody response against West Nile virus infection.
PMID 15919902·J Virol·2005
7-preclinical
Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus.
PMID 15852016·Nat Med·2005
4-observational
Continuation of a randomized, double-blind, multicenter study of linezolid versus vancomycin in the treatment of patients with nosocomial pneumonia.
PMID 12852712·Clin Ther·2003
3-trial
Worldwide assessment of linezolid's clinical safety and tolerability: comparator-controlled phase III studies.
PMID 12760854·Antimicrob Agents Chemother·2003
8-other
Linezolid versus ceftriaxone/cefpodoxime in patients hospitalized for the treatment of Streptococcus pneumoniae pneumonia.
PMID 12477321·Scand J Infect Dis·2002
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 850 IVES DAIRY RD STE T1
MIAMI, FL 33179 - Phone
- (305) 652-0640
Quick Facts
- NPI
- 1871836981
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile